title: Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Federico
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Alessandra
authors.initials: A
authors.lastname: Serrao
authors.forename: Luigi
authors.initials: L
authors.lastname: Petrucci
authors.forename: Adriano
authors.initials: A
authors.lastname: Salaroli
authors.forename: Mauro
authors.initials: M
authors.lastname: Nanni
authors.forename: Maria Stefania
authors.initials: MS
authors.lastname: De Propris
authors.forename: Daniela
authors.initials: D
authors.lastname: Diverio
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001752:Blast Crisis / Q000188:drug therapy / Q000235:genetics; D002490:Central Nervous System / Q000473:pathology*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl